SELECT FROM MENU

Therapy Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immuno-therapies

Antibody Drug Conjugates

Antibody-Drug Conjugates

Targeted Therapies in NSCLC

Targeted Therapies in NSCLC

Targeted Therapies in NSCLC Current Standards and Challenges in ALK+ and EGFR+ NSCLC Oliver Gautschi Unlocking Synergies with Chemo, Bispecifics and TKIs Jarushka Naidoo LATEST ADVANCES IN RECURRENT EGFR+ NSCLC: FOCUS ON MET Nicolas Girard  10 JULY 2025 } 1 h 30 min...

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates